Reshape Lifesciences Inc. buy krebskrebs
Start price
27.06.23
/
50%
€1.28
Target price
27.06.24
€2.00
Performance (%)
-91.52%
End price
28.06.24
-
Summary
This prediction is currently being closed. The BUY prediction by krebskrebs for Reshape Lifesciences Inc. is performing very badly with a performance of -91.52%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Reshape Lifesciences Inc. | - | - | - |
iShares Core DAX® | -0.543% | 1.491% | 13.638% |
iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% |
iShares Nikkei 225® | -2.863% | 2.491% | 12.078% |
iShares S&P 500 | -1.105% | 0.013% | 26.888% |
Comments by krebskrebs for this prediction
In the thread Trading Obalon Therapeutics Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten
In the thread Reshape Lifesciences Inc. diskutieren
Buy mit Kursziel 2,0